LLOYD A ROWLAND Insider Trading $AMLN AMYLIN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LLOYD A ROWLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LLOYD A ROWLAND. LLOYD A ROWLAND is in AMYLIN PHARMACEUTICALS INC ($AMLN) and Vice President & General in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Governance Compliance & Co in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Governance Compliance & Cor in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP Legal & General Counsel in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP, Chief Compliance Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and VP, Gov/Compliance, Secretary in AMYLIN PHARMACEUTICALS INC ($AMLN).
LLOYD A ROWLAND in AMYLIN PHARMACEUTICALS INC
Trading Symbol: AMLNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LLOYD A ROWLAND: VP, Chief Compliance Officer, VP Governance Compliance & Co, VP Governance Compliance & Cor
Holdings: 0 shares
Latest Transaction: Aug 10 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LLOYD A ROWLAND in AMYLIN PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 0.00 | 1,767 | 0 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 0.00 | 10,000 | 0 | 1,767 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 41.34 | 26,799 | 1,107,871 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 36.90 | 23,437 | 864,825 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 24.87 | 17,047 | 423,959 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 22.60 | 30,405 | 687,153 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 18.85 | 32,113 | 605,330 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 18.01 | 12,919 | 232,671 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.54 | 28,649 | 473,854 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.02 | 12,198 | 195,412 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 15.03 | 11,000 | 165,330 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 9.02 | 18,750 | 169,125 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 41.34 | 3,201 | 132,329 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 36.90 | 1,563 | 57,675 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 24.87 | 1,953 | 48,571 | 1,000 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 22.60 | 4,482 | 101,293 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 18.01 | 7,081 | 127,529 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.54 | 5,251 | 86,852 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.02 | 7,802 | 124,988 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 15.03 | 5,000 | 75,150 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 9.02 | 6,250 | 56,375 | 0 | |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 1,360 | 42,160 | 0 | 1.4 K to 0 (-100.00 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 6,614 | 205,034 | 1,360 | 8 K to 1.4 K (-82.94 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 3,192 | 98,952 | 0 | 3.2 K to 0 (-100.00 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 473 | 14,663 | 3,192 | 3.7 K to 3.2 K (-12.91 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 35,014 | 1,085,434 | 0 | 35 K to 0 (-100.00 %) |
Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 412 | 12,772 | 35,014 | 35.4 K to 35 K (-1.16 %) |
Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Grant | A | 14.62 | 823 | 12,032 | 35,426 | 34.6 K to 35.4 K (+2.38 %) |
Mar 29 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | M | 9.02 | 5,000 | 45,100 | 18,750 | |
Mar 29 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | S | 25.00 | 3,000 | 75,000 | 34,603 | 37.6 K to 34.6 K (-7.98 %) |
Mar 29 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | S | 22.83 | 5,000 | 114,150 | 37,603 | 42.6 K to 37.6 K (-11.74 %) |
Mar 29 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Buy | M | 9.02 | 5,000 | 45,100 | 42,603 | 37.6 K to 42.6 K (+13.30 %) |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 16.02 | 12,198 | 195,412 | 12,198 | |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 16.02 | 7,802 | 124,988 | 7,802 | |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Grant | A | 0.00 | 1,529 | 0 | 7,974 | 6.4 K to 8 K (+23.72 %) |
Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Grant | A | 0.00 | 6,700 | 0 | 37,603 | 30.9 K to 37.6 K (+21.68 %) |
Mar 02 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 0.00 | 1,767 | 0 | 11,767 | |
Mar 02 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | D | 0.00 | 1,767 | 0 | 30,903 | 32.7 K to 30.9 K (-5.41 %) |
Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 0.00 | 5,000 | 0 | 10,000 | |
Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | D | 0.00 | 5,000 | 0 | 32,009 | 37 K to 32 K (-13.51 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 15.03 | 11,000 | 165,330 | 11,000 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | A | 15.03 | 5,000 | 75,150 | 5,000 | |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Grant | A | 0.00 | 1,630 | 0 | 6,445 | 4.8 K to 6.4 K (+33.85 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Grant | A | 0.00 | 5,000 | 0 | 36,366 | 31.4 K to 36.4 K (+15.94 %) |
Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Grant | A | 0.00 | 5,300 | 0 | 31,366 | 26.1 K to 31.4 K (+20.33 %) |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Comp ... | Option Exercise | A | 18.01 | 12,919 | 232,671 | 12,919 | |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Comp ... | Option Exercise | A | 18.01 | 7,081 | 127,529 | 7,081 | |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Comp ... | Grant | A | 0.00 | 1,360 | 0 | 4,815 | 3.5 K to 4.8 K (+39.36 %) |
Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Comp ... | Grant | A | 17.83 | 412 | 7,346 | 26,684 | 26.3 K to 26.7 K (+1.57 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | A | 9.02 | 13,750 | 124,025 | 23,750 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | A | 9.02 | 10,000 | 90,200 | 10,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | A | 9.02 | 6,250 | 56,375 | 6,250 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Grant | A | 11.80 | 585 | 6,903 | 25,113 | 24.5 K to 25.1 K (+2.39 %) |
Aug 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | M | 16.54 | 100 | 1,654 | 28,649 | |
Aug 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Sell | S | 35.00 | 100 | 3,500 | 24,427 | 24.5 K to 24.4 K (-0.41 %) |
Aug 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Buy | M | 16.54 | 100 | 1,654 | 24,527 | 24.4 K to 24.5 K (+0.41 %) |
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Option Exercise | A | 24.87 | 17,047 | 423,959 | 17,047 | ||
Mar 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Option Exercise | A | 24.87 | 2,953 | 73,441 | 2,953 | ||
Feb 05 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | Grant | A | 37.00 | 182 | 6,734 | 23,976 | 23.8 K to 24 K (+0.76 %) | |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 16.54 | 2,000 | 33,080 | 28,749 | |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 37.56 | 2,000 | 75,110 | 23,844 | 25.8 K to 23.8 K (-7.74 %) |
Dec 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 16.54 | 2,000 | 33,080 | 25,844 | 23.8 K to 25.8 K (+8.39 %) |
Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 16.54 | 2,000 | 33,080 | 30,749 | |
Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 44.16 | 2,000 | 88,311 | 23,844 | 25.8 K to 23.8 K (-7.74 %) |
Nov 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 16.54 | 2,000 | 33,080 | 25,844 | 23.8 K to 25.8 K (+8.39 %) |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 16.54 | 2,000 | 33,080 | 32,749 | |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 49.67 | 2,000 | 99,341 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
Oct 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 16.54 | 2,000 | 33,080 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 22.60 | 113 | 2,554 | 4,482 | |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 18.85 | 1,887 | 35,570 | 0 | |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 48.99 | 113 | 5,536 | 23,485 | 23.6 K to 23.5 K (-0.48 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 22.60 | 113 | 2,554 | 23,598 | 23.5 K to 23.6 K (+0.48 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 48.99 | 1,887 | 92,452 | 23,485 | 25.4 K to 23.5 K (-7.44 %) |
Sep 06 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 18.85 | 1,887 | 35,570 | 25,372 | 23.5 K to 25.4 K (+8.03 %) |
Aug 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 18.85 | 2,000 | 37,700 | 1,887 | |
Aug 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 46.31 | 2,000 | 92,623 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
Aug 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 18.85 | 2,000 | 37,700 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
Jul 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 18.85 | 2,000 | 37,700 | 3,887 | |
Jul 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 41.00 | 2,000 | 82,000 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
Jul 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 18.85 | 2,000 | 37,700 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
Jun 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 18.85 | 2,000 | 37,700 | 5,887 | |
Jun 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 46.64 | 2,000 | 93,280 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
Jun 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 18.85 | 2,000 | 37,700 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
May 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 11.95 | 3,000 | 35,850 | 0 | |
May 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 3,000 | |
May 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 41.49 | 3,000 | 124,470 | 23,485 | 26.5 K to 23.5 K (-11.33 %) |
May 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 11.95 | 3,000 | 35,850 | 26,485 | 23.5 K to 26.5 K (+12.77 %) |
May 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Sell | S | 41.51 | 2,000 | 83,020 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
May 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Gov/Compliance, ... | Buy | M | 11.95 | 2,000 | 23,900 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
Apr 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 5,000 | |
Apr 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 36.95 | 2,000 | 73,901 | 23,485 | 25.5 K to 23.5 K (-7.85 %) |
Apr 03 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 25,485 | 23.5 K to 25.5 K (+8.52 %) |
Mar 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | A | 36.90 | 23,437 | 864,825 | 23,437 | |
Mar 09 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | A | 36.90 | 1,563 | 57,675 | 1,563 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 25 | 299 | 0 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 1,975 | 23,601 | 7,000 | |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 37.39 | 1,975 | 73,838 | 23,485 | 25.5 K to 23.5 K (-7.76 %) |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 1,975 | 23,601 | 25,460 | 23.5 K to 25.5 K (+8.41 %) |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 37.39 | 25 | 935 | 23,485 | 23.5 K to 23.5 K (-0.11 %) |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 25 | 299 | 23,510 | 23.5 K to 23.5 K (+0.11 %) |
Mar 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Grant | A | 33.07 | 248 | 8,202 | 23,485 | 23.2 K to 23.5 K (+1.07 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 25 | |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 38.92 | 2,000 | 77,840 | 23,237 | 25.2 K to 23.2 K (-7.92 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 25,237 | 23.2 K to 25.2 K (+8.61 %) |
Feb 02 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Grant | A | 36.07 | 416 | 15,005 | 23,237 | 22.8 K to 23.2 K (+1.82 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 2,025 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 3,000 | 17,190 | 0 | |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 36.10 | 2,000 | 72,200 | 22,821 | 24.8 K to 22.8 K (-8.06 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 24,821 | 22.8 K to 24.8 K (+8.76 %) |
Jan 04 2007 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 3,000 | 17,190 | 22,821 | 19.8 K to 22.8 K (+15.14 %) |
Dec 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Gift | G | 0.00 | 135 | 0 | 19,821 | 20 K to 19.8 K (-0.68 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 11.95 | 2,000 | 23,900 | 4,025 | |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 39.39 | 2,000 | 78,780 | 19,956 | 22 K to 20 K (-9.11 %) |
Dec 05 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 11.95 | 2,000 | 23,900 | 21,956 | 20 K to 22 K (+10.02 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 2,000 | 11,460 | 3,000 | |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 44.01 | 2,000 | 88,020 | 19,956 | 22 K to 20 K (-9.11 %) |
Nov 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 2,000 | 11,460 | 21,956 | 20 K to 22 K (+10.02 %) |
Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 2,000 | 11,460 | 5,000 | |
Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 43.07 | 2,000 | 86,148 | 19,956 | 22 K to 20 K (-9.11 %) |
Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 2,000 | 11,460 | 21,956 | 20 K to 22 K (+10.02 %) |
Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 500 | 2,865 | 7,000 | |
Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 1,500 | 8,385 | 0 | |
Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 45.21 | 500 | 22,605 | 19,493 | 20 K to 19.5 K (-2.50 %) |
Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 500 | 2,865 | 19,993 | 19.5 K to 20 K (+2.57 %) |
Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 45.21 | 1,500 | 67,815 | 19,493 | 21 K to 19.5 K (-7.15 %) |
Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 1,500 | 8,385 | 20,993 | 19.5 K to 21 K (+7.70 %) |
Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 1,500 | |
Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 47.43 | 2,000 | 94,864 | 19,493 | 21.5 K to 19.5 K (-9.31 %) |
Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 21,493 | 19.5 K to 21.5 K (+10.26 %) |
Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 3,500 | |
Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 48.02 | 2,000 | 96,041 | 19,493 | 21.5 K to 19.5 K (-9.31 %) |
Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 21,493 | 19.5 K to 21.5 K (+10.26 %) |
Jun 30 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 5,500 | |
Jun 30 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 19,493 | 17.5 K to 19.5 K (+11.43 %) |
Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 7,500 | |
Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 17,493 | 15.5 K to 17.5 K (+12.91 %) |
Jun 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 9,500 | |
Jun 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 45.57 | 2,000 | 91,140 | 15,493 | 17.5 K to 15.5 K (-11.43 %) |
Jun 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 17,493 | 15.5 K to 17.5 K (+12.91 %) |
May 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | A | 41.34 | 26,799 | 1,107,871 | 26,799 | |
May 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | A | 41.34 | 3,201 | 132,329 | 3,201 | |
May 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 11,500 | |
May 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 43.00 | 2,000 | 86,000 | 15,493 | 17.5 K to 15.5 K (-11.43 %) |
May 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 17,493 | 15.5 K to 17.5 K (+12.91 %) |
Apr 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 13,500 | |
Apr 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 46.89 | 2,000 | 93,770 | 15,493 | 17.5 K to 15.5 K (-11.43 %) |
Apr 04 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 17,493 | 15.5 K to 17.5 K (+12.91 %) |
Mar 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 3,000 | 16,770 | 15,500 |